Business
Clearwater Paper Reports Fourth Quarter and Year End 2025 Results
SPOKANE, Wash., February 18, 2026--Clearwater Paper Corporation (NYSE:CLW), a premier independent supplier of bleached paperboard to North American converters, today reported financial results for the fourth quarter and year ended December 31, 2025.
About this update from Clearwater Paper Corporation
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":990,"height":377,"url":"https://media.zenfs.com/en/business-wire.com/47a98e6bc88eb08c65f54473ae090436"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/vnOa8maHs7JFE9A3YANW0Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTM2NjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/47a98e6bc88eb08c65f54473ae090436","width":960,"height":366},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/kfAXpVm9vea8YJ6iR7jnuA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTE5ODA7aD03NTQ7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/47a98e6bc88eb08c65f54473ae090436","width":990,"height":377}},"lazy":false},{"type":"text","content":"SPOKANE, Wash., February 18, 2026--(BUSINESS WIRE)--Clearwater Paper Corporation (NYSE:CLW), a premier independent supplier of bleached paperboard to North American converters, today reported financial results for the fourth quarter and year ended December 31, 2025.","length":266,"tagName":"p"},{"type":"text","content":"2025 FULL YEAR HIGHLIGHTS","length":25,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Net sales of $1.6 billion, up 12% compared to 2024, with volumes up 14%, primarily from operating the Augusta facility for the full year","length":136,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Net loss from continuing operations of $53 million, or $3.28 per diluted share, primarily driven by a $48 million non-cash goodwill impairment, partly offset by insurance proceeds","length":179,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Adjusted EBITDA improved to $107 million from $36 million in 2024, driven by over $50 million in fixed‑cost reductions, including $16 million in SG&A savings that lowered SG&A costs from 8.4% to 6.5% of net sales","length":220,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Significant improvement in execution of planned major maintenance outages, with all three completed on target at a total direct cost of approximately $50 million","length":161,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Successfully completed integration of the Augusta mill and separation of the tissue business, both completed ahead of schedule and below targeted costs","length":151,"tagName":"p","a...